Invasive pulmonary Aspergyllosis in COPD patient
DOI:
https://doi.org/10.32818/reccmi.a5n1a12Keywords:
invasive pulmonary aspergillosis, aspergillus fumigatus, chronic obstructive pulmonary disease (COPD), fever of unknown origin.Abstract
Severe COPD patient admitted to hospital with sustained fever, dyspnea, productive cough and constitutional syndrome, following several hospitalizations in the previous months due to superinfection with Pseudomonas aeruginosa. After investigation, the chronic form of Invasive Pulmonary Aspergillosis was diagnosed. The patient was treated with antifungals for 8 weeks, achieving clinical and radiological improvement, and sputum negativization. A high index of suspicion of this entity is very important for early diagnosis and early treatment in bronchopaths, since mortality has been estimated to reach 80-95% in untreated patients.
Downloads
Metrics
References
Fortún J, Carratalá J, Gavaldá J, Lizasoain M, Salavert M, de la Cámara R, et al. Recomendaciones sobre el tratamiento de la enfermedad fúngica invasiva por Aspergillus spp y otros hongos filamentosos de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Actualización 2011. Enferm Infecc Microbiol Clin. 2011; 29(6): 435-454. https://doi.org/10.1016/j.eimc.2011.01.010.
Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007; 30(4): 782-800. https://doi.org/10.1183/09031936.00062206.
Trof RJ, Beishuizen A, Debets-Ossenkopp YJ, Girbes AR, Groeneveld AB. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med. 2007; 33(10): 1694-1703. https://doi.org/10.1007/s00134-007-0791-z.
Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006; 43(5): 577-584. https://doi.org/10.1086/505870.
Valle JM, González-Barcala FJ, Álvarez-Dobaño JM, Valdés L. La aspergilosis pulmonar invasiva en la enfermedad pulmonar obstructiva crónica. Rev Med Chil. 2010; 138(5): 612-620. https://doi.org/S0034-98872010000500013.
Stergiopoulou T, Meletiadis J, Roilides E, Kleiner DE, Schaufele R, Roden M, et al. Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. Am J Clin Pathol. 2007; 127(3): 349-355. https://doi.org/10.1309/UJRV9DL-C11RM3G8R.
Patterson TF, Thompson GR 3rd, Denning DW, Fishman JA, Hadley S, Herbrecht R, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016; 63(4): e1-e60. https://doi.org/10.1093/cid/ciw326.
Patterson TF. Treatment and prevention of invasive aspergillosis. Post TW, ed. UpToDate. Kauffman CA: UpToDate Inc. https://www.uptodate.com (último acceso: julio 2017).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 María Luisa García-Aguinaga, Clara Tamiri Rodríguez-González, Edgar Joseph Sabado-Angngasing, Rafael Velayos-Rubio, Juan González-González
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Permite compartir, copiar y redistribuir el material en cualquier medio o formato, bajo los siguientes términos:
Reconocimiento: debe otorgar el crédito correspondiente, proporcionar un enlace a la licencia e indicar si se realizaron cambios. Puede hacerlo de cualquier manera razonable, pero no de ninguna manera que sugiera que el licenciante lo respalda a usted o su uso.
No comercial: no puede utilizar el material con fines comerciales.
No Derivados: si remezcla, transforma o construye sobre el material, no puede distribuir el material modificado.
Sin restricciones adicionales: no puede aplicar términos legales o medidas tecnológicas que restrinjan legalmente a otros de hacer cualquier cosa que permita la licencia.
